Completed Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response. NCT03578367 Conditions Bone Marrow Diseases, CML, Chronic Disease, +13 more Locations Georgia Regents University — Augusta, Georgia, United States Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland, United States Novartis Investigative Site — Vienna, Austria Novartis Investigative Site — Montreal, Quebec, Canada View all 30 locations View more locations Show fewer locations Loading locations... View Trial Details
